Objective: To evaluate the rate, causes and variables related to emergency hospital readmission after scheduled major lung resection.
Setting: An university general hospital in a managed care health system.
Methods: Databases of 727 patients undergoing scheduled major lung resection between 1994 and 2003 have been reviewed, excluding hospital mortality from the analysis. The studied outcome was the occurrence of emergency hospital readmission by any surgery-related cause, at any centre, during the first 30 days after discharge. Independent studied variables were: age of the patient, body mass index, predicted postoperative FEV1% (ppoFEV1%), type of surgery (lobectomy or pneumonectomy), postoperative morbidity and length of stay (LOS). Descriptive statistics have been performed and forward step-wise logistic regression has been used to select predictive variables.
Results: Rate of emergency readmission was 6.9% (50 cases); 3 patients (6%) died. Pleural empyema without bronchial fistula (18 cases) was the most frequent cause of readmission. On logistic-regression analysis, pneumonectomy (odds ratio 3.84; 95%CI: 1.98-7.45) and major postoperative morbidity (odds ratio 2.42; 95%CI: 1.26-4.66) showed independent correlation to the outcome.
Conclusions: Readmission rate after lung resection is around 7% and it is not influenced by LOS; patients experiencing major postoperative morbidity and pneumonectomy cases have the highest probability to be readmitted within 30 days after lung resection.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejcts.2004.05.035 | DOI Listing |
Discov Oncol
January 2025
Division of Hematology Oncology, Penn State College of Medicine, 500 University Dr, Hershey, PA, 17033, USA.
Background: The role of adjuvant chemotherapy in early-stage small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC) remains unclear, particularly for small tumors. This study assesses the survival benefits of adjuvant chemotherapy after surgical resection with a novel focus on tumors less than 1 cm.
Materials And Methods: Data from the National Cancer Database (NCDB) was extracted for patients with SCLC (n = 11,962) and LCNEC (n = 6821) who underwent surgical resection between 2004 and 2020.
Pediatr Rep
January 2025
Clinic for Pediatric Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Introduction: In this single-center retrospective analysis, we present case data and insights gathered over the past eight years. Additionally, we computed postnatal, pre-therapy lesion-to-lung ratios of Congenital Pulmonary Airway Malformations (CPAMs) to retrospectively assess potential outcome prediction using lesion-to-lung ratios.
Methods: Data were collected between 2015 and 2022.
Cureus
December 2024
Neurological Surgery, Hospital Central do Funchal, Funchal, PRT.
Metastases to the pituitary gland are a rare finding, with breast and lung being the most common metastases in this anatomical region. Pituitary melanoma metastases reports are thus sparse, and both diagnosis and treatment are challenging. We present the case of a 66-year-old woman with pituitary melanoma metastasis who presented with symptoms of anterior pituitary dysfunction and headache.
View Article and Find Full Text PDFFront Surg
January 2025
Department of Orthopedics, Dokuz Eylul University, Izmir, Türkiye.
Ureteral papillary carcinoma is a rare subtype of urothelial carcinoma, ranking fourth among cancers following prostate (or breast) cancer, lung cancer, and colorectal cancer. Although previous studies have documented bone metastases mainly in the pelvis, spine, ribs, and femur, this case report presents the first recorded instance of metastasis occurring in the acromioclavicular joint. A 62-year-old woman with a history of left flank pain and macroscopic hematuria underwent a left nephroureterectomy, which revealed ureteral papillary carcinoma.
View Article and Find Full Text PDFWorld J Surg Oncol
January 2025
Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Objective: With the wide use of CT scan in clinical practice, more lung cancer was diagnosed in resectable stage. Pathological examination and genetic testing have become a routine procedure for lung adenocarcinoma following radical resection. This study analyzed special pathological components and gene mutations to explore their relationship with clinical characteristics and overall survival.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!